SCHEMBL6965249

SCHEMBL6965249

Cc1cc(-c2cc(O)c(SCCc3ccccc3)c(=O)o2)ccc1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.40
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40
ALOX5 P09917 3/20 0.39
ESR1 P03372 3/20 0.38
ESR2 Q92731 3/20 0.38
PTGES O14684 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
POLB P06746 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
MAPT P10636 3/20 0.36
KDM4E B2RXH2 2/20 0.36
CYP3A4 P08684 2/20 0.36
HPGD P15428 2/20 0.36
MAPK1 P28482 2/20 0.36
TNKS O95271 1/20 0.36
ALDH1A1 P00352 1/20 0.36
PARP1 P09874 1/20 0.36
ST6GAL1 P15907 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6965244 0.91 ALOX5 (0.38) ALOX5PTGESSMN1; SMN2POLBL3MBTL1
SCHEMBL6954657 0.87 SMN1; SMN2 (0.44) ALOX5PTGESSMN1; SMN2POLBL3MBTL1
SCHEMBL6960622 0.86 SMN1; SMN2 (0.49) HSD17B1PTGESSMN1; SMN2POLBL3MBTL1
SCHEMBL6964575 0.86 FFAR4 (0.44) PTGESPOLBL3MBTL1MAPTKDM4E
SCHEMBL6959805 0.86 PTGS2 (0.46) ALOX5PTGESSMN1; SMN2POLBL3MBTL1
SCHEMBL6952786 0.86 L3MBTL1 (0.39) SMN1; SMN2POLBL3MBTL1MAPTKDM4E
SCHEMBL6956148 0.85 PTGES (0.45) HSD17B1ESR1ESR2PTGESSMN1; SMN2
SCHEMBL6963073 0.85 PPARD (0.43) L3MBTL1MAPTMEN1KMT2A
SCHEMBL6959678 0.84 SMN1; SMN2 (0.42) ALOX5SMN1; SMN2POLBL3MBTL1MAPT
SCHEMBL6964247 0.83 AR (0.42) ESR1ESR2SMN1; SMN2POLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP claimed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO claimed
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed